The Business Excellence Strategy group within Global Portfolio Strategy & Operations works side-by-side with the Aesthetics R&D executive team on many of the most pressing issues facing the organization, both in the short- and long-term. Work from this team will have a direct impact on the future success of AbbVie.
As an Associate Director of Business Excellence Portfolio Strategy, you will partner with leaders across AbbVie to optimize the value of our portfolio and current/future assets. The role is seeking a high performing team member who has demonstrated an interest and expertise in the biopharma industry and strong desire to advance our strategic agenda and support mission-critical assets + initiatives that will make a real difference for AbbVie’s patients. In return, the Business Excellence group will provide high profile, high impact projects and professional development experiences spanning the entire drug development value chain.
The position requires strong analytical skills and the ability to translate strategic vision into tactical action. It will be imperative in this role to identify the highest impact ideas and plans and focus efforts to work effectively in a cross-functional team.
This position is located in our Irvine, CA office (hybrid onsite days at Tues, Wed and Thurs).
Responsibilities:
• Drive end-to-end strategic innovation, communication and execution on Allergan Aesthetics portfolio + assets in partnership with the R&D + Commercial Leadership Teams. Areas of focus include strategic planning, scenario evaluation, and data-driven problem solving spanning the breadth of drug/aesthetic medical device development.
• Support R&D strategy processes including: Annual franchise strategy reviews and Strategy Long Range Plans, Therapeutic Area strategy and pipeline reviews, and high priority Asset Strategy Team support. This will require both strong project management and ability to generate and communicate strategic insights to leaders and franchise / asset strategy teams.
Support and lead strategic initiatives that address mission-critical questions and position AbbVie for future success, such as:
• R&D competitive intelligence initiatives, including evidence-based competitive assessments, ELT scientific communications, and ongoing monitoring of key competitor activities across pipeline, scientific communications, and commercial channels
• Dedicated strategic decision support for key pipeline assets through Asset Strategy Leader + Project & Portfolio Management partnership, governance deck development, pressure-testing of business cases, and milestone storytelling from pre-concept through pivotal trial design
• Development and operationalization of R&D pipeline metrics and KPIs (e.g., cycle times, productivity indices, milestone tracking) for enterprise reporting, potentially including data collection, stakeholder alignment, and dashboard/visualization design
• Structured competitive benchmarking analyses across franchises, synthesizing external best practices and internal data into actionable recommendations for R&D leadership
• Rapid-response support to R&D leadership on high importance / visibility priorities.
• Individual modules within complex, cross-functional initiatives, including driving the problem-solving process supporting research and analytics, and distilling pragmatic recommendations for management consideration.
• Help communicate our strategy at executive forums across AbbVie.
• Monitor, understand, and prioritize external trends of relevance to the enterprise, and help determine how AbbVie should prepare and/or respond.